HIV-HCV co-infection: where are we now?

被引：1

作者：

Piroth, L. ^{[1
]}

机构：

[1] CHU, Dept Infectiol, F-21079 Dijon, France

来源：

GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2009年 / 33卷

关键词：

CHRONIC HEPATITIS-C; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; VIRUS-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; LIVER-RELATED MORTALITY; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; IMMUNODEFICIENCY; PROGRESSION; TRIAL;

D O I：

10.1016/S0399-8320(09)72446-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatitis C virus (HCV) infection remains a major concern in human immunodeficiency virus (HIV) infected people because of its prevalence and clinical consequences. Management of these patients has evolved, becoming more and more demanding on therapeutic goals and means, not only regarding antiretroviral therapy but also anti-HCV therapy. Thus, if the results of current management are encouraging, they nevertheless is insufficient. It underlines the imperative need for a better comprehension of the essential elements of HCV-HIV co-infection natural history and of the determinants of response to HCV therapy, in particular with pivotal, studies such as the ANRS HC 02 RIBAVIC trial. (C) 2009 Elsevier Masson SAS. All rights reserved.

引用

页码：S94 / S96

页数：3

共 50 条

[1] HIV-HCV co-infection
Daruich, J.
[J]. HAEMOPHILIA, 2008, 14 : 38 - 38
[2] Managing HIV-HCV co-infection
Rockstroh, J.
[J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 7 - 7
[3] HIV-HCV co-infection among blood donors
Mukonde, Frank
[J]. RETROVIROLOGY, 2005, 2 (Suppl 1)
[4] HIV-HCV Co-infection Among Blood Donors
Frank Mukonde
[J]. Retrovirology, 2
[5] HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications
Andreoni, M.
Giacometti, A.
Maida, I.
Meraviglia, P.
Ripamonti, D.
Sarmati, L.
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (11) : 1473 - 1483
[6] HIV-HCV co-infection: conflicts in treatment and clinical outcome
Rommel, F
[J]. HAEMOPHILIA, 2000, 6 : 37 - 38
[7] Evaluation of the HIV-HCV co-infection status in a cohort of southeastern of Spain
Moreno Hernandez, A.
Smilg Nicolas, C.
Vera Mendez, F.
Martinez Madrid, O.
Jimeno Almazan, A.
Alcalde Encinas, M.
Alcaraz Vidal, B.
Trujillo Santos, J.
Tornel Sanchez, G.
Vega Cervantes, J.
Mozo Cuadrado, M.
Belmonte Martinez, L.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 89 - 90
[8] Liver enzymes elevation after HAART in HIV-HCV co-infection
Servin-Abad, L
Molina, E
Baracco, G
Arosemena, L
Regev, A
Jeffers, L
Schiff, E
[J]. JOURNAL OF VIRAL HEPATITIS, 2005, 12 (04) : 429 - 434
[9] HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians
Ingiliz, Patrick
Rockstroh, Juergen K.
[J]. LIVER INTERNATIONAL, 2012, 32 (08) : 1194 - 1199
[10] Decreased miR-122 Levels With HCV Clearance in HIV-HCV Co-Infection
Dubin, Perry H.
Yuan, Hejun
Devine, R. Kenton
Jain, Mamta K.
Hynan, Linda S.
Lee, William M.
[J]. GASTROENTEROLOGY, 2013, 144 (05) : S976 - S976

← 1 2 3 4 5 →